5,005
edits
Main Page: Difference between revisions
From W8MD weight loss and sleep centers
no edit summary
No edit summary |
No edit summary |
||
| Line 51: | Line 51: | ||
|} | |} | ||
<h2 style="margin:0;background-color:#dfefdf;font-size:120%;font-weight:bold;border:1px solid #defbfa;text-align:left;color:#000;padding:0.2em 0.4em;">'''Weight loss news'''</h2> | <h2 style="margin:0;background-color:#dfefdf;font-size:120%;font-weight:bold;border:1px solid #defbfa;text-align:left;color:#000;padding:0.2em 0.4em;">'''Weight loss news'''</h2> | ||
[[File:W8MD-Team.jpg| | [[File:W8MD-Team.jpg|500px|right]] | ||
In October 2022, the Food and Drug Administration (FDA) granted Mounjaro, a diabetes drug, a fast-track designation for weight loss, leading to speculation that it will be approved for weight loss use this year due to its promising results in clinical trials. | In October 2022, the Food and Drug Administration (FDA) granted Mounjaro, a diabetes drug, a fast-track designation for weight loss, leading to speculation that it will be approved for weight loss use this year due to its promising results in clinical trials. | ||
[[File:Weight-loss-success-stories.jpeg|thumb|Weight loss success stories]] | [[File:Weight-loss-success-stories.jpeg|thumb|Weight loss success stories]] | ||
